Announce Date | 04/30/2025 |
EPS Normalized Actual | $2.21 (Miss by $-0.31) |
EPS GAAP Actual | $2.21 (Miss by $-0.31) |
Revenue Actual | $16.452B |
Revenue Surprise | Beat by $16452M |
Announce Date | 09/30/2025 (Pre-Market) |
EPS Normalized Estimate | $4.36017 |
EPS GAAP Estimate | $4.36017 |
Revenue Estimate | $15.652441571B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0 | -2.52183 | 16.452B | 7.25% | 2399.9M |
FQ4 2024 (Dec 2024) | 0 | -6.27232 | 16.506B | 10.14% | 2782.23M |
FQ3 2024 (Sep 2024) | 4.39 | 2.01312 | 16.627B | 20.56% | 2060.9M |
FQ2 2024 (Jun 2024) | 0 | -0.27838 | 15.714B | 11.04% | 1669.07M |
FQ1 2024 (Mar 2024) | 0 | -3.93201 | 15.259B | 19.15% | 2501M |
FQ4 2023 (Dec 2023) | 0 | -3.94046 | 14.832B | 100% | 2137.77M |
FQ3 2023 (Sep 2023) | -0.16 | -0.16 | 13.208B | 100% | 13208M |
FQ2 2023 (Jun 2023) | 0 | 0 | 13.979B | 100% | 13979M |
FQ4 Announce Date
09/30/2025 (Pre-Market)
Consensus EPS Estimates
4.36017
Consensus Revenue Estimates
15.652441571B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 8.32087 | -- | 8.32087 | 8.32087 | 1 |
FQ3 2027 (Sep 2027) | 5.30847 | -- | 5.30847 | 5.30847 | 1 |
FQ2 2027 (Jun 2027) | 3.15583 | -- | 3.15583 | 3.15583 | 1 |
FQ1 2027 (Mar 2027) | 6.66413 | -- | 6.66413 | 6.66413 | 1 |
FQ4 2026 (Dec 2026) | 7.46678 | -- | 7.46678 | 7.46678 | 1 |
FQ3 2026 (Sep 2026) | 4.66429 | -- | 4.66429 | 4.66429 | 1 |
FQ2 2026 (Jun 2026) | 3.23726 | -- | 3.23726 | 3.23726 | 1 |
FQ1 2026 (Mar 2026) | 6.29025 | -- | 6.29025 | 6.29025 | 1 |
FQ4 2025 (Dec 2025) | 6.83643 | -- | 6.83643 | 6.83643 | 1 |
FQ3 2025 (Sep 2025) | 4.36017 | -0.68 | 4.36017 | 4.36017 | 1 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 17.45B | -- | 17.45B | 17.45B | 1 |
FQ3 2027 (Sep 2027) | 18.59B | -- | 18.59B | 18.59B | 1 |
FQ2 2027 (Jun 2027) | 17.94B | -- | 17.94B | 17.94B | 1 |
FQ1 2027 (Mar 2027) | 16.55B | -- | 16.55B | 16.55B | 1 |
FQ4 2026 (Dec 2026) | 16.13B | -- | 16.13B | 16.13B | 1 |
FQ3 2026 (Sep 2026) | 17.19B | -- | 17.19B | 17.19B | 1 |
FQ2 2026 (Jun 2026) | 16.64B | -- | 16.64B | 16.64B | 1 |
FQ1 2026 (Mar 2026) | 15.35B | -7.17 | 15.35B | 15.35B | 1 |
FQ4 2025 (Dec 2025) | 14.78B | -11.67 | 14.78B | 14.78B | 1 |
FQ3 2025 (Sep 2025) | 15.65B | -6.23 | 15.65B | 15.65B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
1
EPS # of Misses
6
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 2.52183 | 0 | -2.52183 | -INF% |
FQ4 2024 (Dec 2024) | 6.27232 | 0 | -6.27232 | -INF% |
FQ3 2024 (Sep 2024) | 2.37688 | 4.39 | 2.01312 | 45.86% |
FQ2 2024 (Jun 2024) | 0.27838 | 0 | -0.27838 | -INF% |
FQ1 2024 (Mar 2024) | 3.93201 | 0 | -3.93201 | -INF% |
FQ4 2023 (Dec 2023) | 3.94046 | 0 | -3.94046 | -INF% |
FQ3 2023 (Sep 2023) | -0.16 | -0.16 | 100% | |
FQ2 2023 (Jun 2023) | 0 | 0 | NAN% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $14.05B | $16.45B | $2399.9M | 14.59% |
FQ4 2024 (Dec 2024) | $13.72B | $16.51B | $2782.23M | 16.86% |
FQ3 2024 (Sep 2024) | $14.57B | $16.63B | $2060.9M | 12.39% |
FQ2 2024 (Jun 2024) | $14.04B | $15.71B | $1669.07M | 10.62% |
FQ1 2024 (Mar 2024) | $12.76B | $15.26B | $2501M | 16.39% |
FQ4 2023 (Dec 2023) | $12.69B | $14.83B | $2137.77M | 14.41% |
FQ3 2023 (Sep 2023) | $0B | $13.21B | $13208M | 100% |
FQ2 2023 (Jun 2023) | $0B | $13.98B | $13979M | 100% |